ROLE OF ADJUVANT GAMMA-THERAPY IN THE TREATMENT OF RENAL CANCER
Data on 435 patients with pT1N0M0 renal cancer (RC) and grade (G)2-4 and pT1–4N0–2M0 RC and G1–4 were retrospectively analyzed. A control group (n = 212) underwent nephrectomy only; in a study group (n = 223), 5-fluorouracil 500 mg/m2 and leucovorin 200 mg/m2 were injected at a 5-hour interval befor...
Main Authors: | F. R. Dzhabarov, A. N. Shevchenko, L. Ya. Rozenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-07-01
|
Series: | Onkourologiâ |
Subjects: | |
Online Access: | https://oncourology.abvpress.ru/oncur/article/view/45 |
Similar Items
-
ROLE OF ADJUVANT GAMMA-THERAPY IN THE TREATMENT OF RENAL CANCER
by: F. R. Dzhabarov, et al.
Published: (2014-07-01) -
The Significance of Adjuvant Therapy for Extrahepatic Cholangiocarcinoma After Surgery
by: Wang G, et al.
Published: (2019-12-01) -
Adjuvant chemotherapy for rectal cancer with complete pathological response (pCR) may not be necessary: a pooled analysis of 5491 patients
by: Xiang Hu, et al.
Published: (2019-05-01) -
The Contribution of Adding Chemoradiotherapy to Adjuvant Chemotherapy in Pancreatic Cancer Patients
by: Gökhan Uçar, et al.
Published: (2020-12-01) -
Adjuvant chemoradiotherapy for positive hepatic ductal margin on cholangiocarcinoma
by: Teiichi Sugiura, et al.
Published: (2020-07-01)